2022 Swedish procedure coding classification (KVÅ) released

22

Nov 2021

In November 2021, the National Board of Health and Welfare released an annual update of the Swedish procedure coding system (Classification of Health Care Measures, KVÅ) that will come into force in January 2022. KVÅ includes two parts – medical procedures (KMÅ) and surgical procedures (KKÅ) divided by chapters based on anatomical principles.

In 2022, six new surgical procedure codes will be introduced, five of which related to ECLS (extracorporeal life support) and ECMO (extracorporeal membrane oxygenation), and one code for bronchoscopy. Some examples are provided below:

  • FXF05 Peripheral percutaneous cannulation for extracorporeal life support (ECMO/ECLS);
  • FXF30 Combination of central and peripheral cannulation for extracorporeal life support (ECMO/ECLS);
  • UGC32 Bronchoscopy with electromagnetic navigation.

Furthermore, structural changes will be made in Chapter V "Operations on the aorta, peripheral vessels, and lymphatic system," which was introduced in 2021 (replaced Chapter P). It covers the entire artery tree from the aortic ascendant after the coronary arteries depart. In 2022, sub-chapter VK "Operations on the femoral artery and its branches" (122 codes) will be deleted and replaced by two new sub-chapters:

  • VL "Operations on infrapopliteal arteries as well as operations from the femoral and popliteal arteries to infrapopliteal arteries" with a total of 145 new codes;
  • VJ "Operations on the femoral and popliteal arteries as well as the AV graft and AV fistulas from the femoral artery" with a total of 173 new codes.

In 2022, a total of 53 new medical procedure codes (KMÅ) will be added concerning extracorporeal treatment, ENT, in-vitro diagnostics, neurology, orthopedic, and others. Some examples are provided below:

  • DD021 Upgrading of speech processor for a cochlear implant;
  • DV100 Treatment with extracorporeal carbon dioxide removal (ECCO2R);
  • DV101 Treatment with venovenous (VV) extracorporeal membrane oxygenation (ECMO);
  • AJ100 Triglyceride Exhalation Test. Note: used to diagnose exocrine pancreatic insufficiency, measuring the ability to cleave triglyceride enzymatically;
  • AN105 Fracture risk assessment based on clinical factors with or without FRAX.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

25

Nov 2021

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in October 2021. More than 20 recommendations were published in relation to the registration, modification of registration conditions, renewal of registration of devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular, peripheral vascular, neurovascular and neuromodulation, and other groups of devices, as well as medical aids.

Read more

23

Nov 2021

In late October 2021, the Treatment Council (Behandlingsråd) published three topics chosen for developing the so-called major analyses (større analyser) in 2022. The selected topics include patient-centered diabetes technology, hand-held focused ultrasound in emergency medicine, and artificial intelligence as decision support for colonoscopy.

Read more

18

Nov 2021

In October 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (genicular artery embolization for pain from knee osteoarthritis, laparoscopic renal denervation for loin pain hematuria syndrome, percutaneous endovascular forearm arteriovenous fistula creation for hemodialysis access), and one new Medical Technologies Guidance (DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography). Also, two new clinical guidelines were published.

Read more

16

Nov 2021

In late October 2021, the BfArM (Federal Institute for Drugs and Medical Devices) has published the final version of the 2022 OPS procedure coding classification. The OPS, together with the ICD-10-GM (International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification), forms the basis for the reimbursement systems in outpatient and inpatient care.

Read more

08

Nov 2021

In late September 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, has published Bulletins 0179 and 0076 with changes to be implemented no later than January 01, 2022. Four new procedure codes related to gynecology, robotic surgery in the pulmonology area, and orthopedics, and four new diagnostic codes were introduced.

Read more